Skip to main content
search

Late Clinical

Sign up

Latest resources

Featured resource

Late clinical resources

How Certara MIDD Experts Overcame Client Regulatory Challenges
How Certara MIDD Experts Overcame Client Regulatory ChallengesCase Study

How Certara MIDD Experts Overcame Client Regulatory Challenges

Certara’s Model-Informed Drug Development (MIDD) approach leverages an integrated, quantitative systems methodology to accelerate regulatory approval and commercial success while minimizing time and costs.…
Standardizing Real World Data in Rare Disease: ATHN’s Journey
Standardizing Real World Data in Rare Disease: ATHN’s JourneyCase Study

Standardizing Real World Data in Rare Disease: ATHN’s Journey

The American Thrombosis and Hemostasis Network (ATHN), a not-for-profit organization, has been improving care and advancing research for individuals with…
What’s New in Phoenix 8.6?
What’s New in Phoenix 8.6?Webinar

What’s New in Phoenix 8.6?

Date: To be announced | Coming in Q2 2025Solutions: Preclinical, Early Clinical, Late Clinical, RegulatoryProducts: Phoenix™ Get a first look…
Mechanistic Modeling to Meet Challenges in ADC Development
Mechanistic Modeling to Meet Challenges in ADC DevelopmentBlog

Mechanistic Modeling to Meet Challenges in ADC Development

April 4, 2025 Navigating the challenges in antibody-drug conjugates (ADCs) development requires overcoming complex hurdles in through the entire development…

Latest late clinical blogs

All Late Clinical resources

Model-informed Formulation Development: Bridging Experimental Data and Mechanistic Modeling

Webinar - Resources LP - Upcoming, Webinar

Write Quicker PBPK Reports with the Simcyp Report Assistant

Certara Products - Simcyp, Modeling and Simulation - PBPK, Blog

Model-Based Meta-Analysis (MBMA) for Relative Treatment Effects and Absolute Outcomes: A Focus on Concepts and Applications 

Model-Based Meta-Analysis (MBMA), Webinar - Resources LP - Upcoming, Webinar

How Certara MIDD Experts Overcame Client Regulatory Challenges

Homepage Latest, Case Study

Standardizing Real World Data in Rare Disease: ATHN’s Journey

Certara Products - Pinnacle 21, Certara Services, Homepage Latest, Case Study

What’s New in Phoenix 8.6?

Webinar

Mechanistic Modeling to Meet Challenges in ADC Development

Modeling and Simulation - QSP, Blog

Unlocking the Power of Oligonucleotide Therapeutics: A Model-Informed Approach with Certara & Ionis

Clinical Pharmacology, Webinar

Model-Based Meta-Analysis for All Phases of Drug Development: Capturing the Full Potential of Published Clinical Trial Outcomes [APAC Webinar]

CODEX, Model-Based Meta-Analysis (MBMA), Webinar

Unlocking Success with Phoenix Hosted: Real-World Customer Stories

Certara Products - Phoenix, Case Study

Calculating AUC (Linear and Log-linear)

Certara Products - Phoenix, Modeling and Simulation - PK/PD, Blog, Knowledge Base

Accumulation: What It Means and How to Calculate It

Certara Products - Phoenix, Modeling and Simulation - PK/PD, Blog, Knowledge Base
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.